LEADING MITOCHONDRIAL MEDICINE Trademark

Trademark Overview

On Wednesday, November 12, 2014, a trademark application was filed for LEADING MITOCHONDRIAL MEDICINE with the United States Patent and Trademark Office. The USPTO has given the LEADING MITOCHONDRIAL MEDICINE trademark a serial number of 86452304. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 24, 2018. This trademark is owned by Stealth Peptides International Inc.. The LEADING MITOCHONDRIAL MEDICINE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biopharmaceutical preparations which target cell mitochondria and are used for the prevention and treatment of cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; biological preparations which target cell mitochondria and are used for the prevention of and treatment of cellular abnormalities

Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the cardiovascular, renal, ophthalmic, neurologic and metabolic system fields
leading mitochondrial medicine

General Information

Serial Number86452304
Word MarkLEADING MITOCHONDRIAL MEDICINE
Filing DateWednesday, November 12, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 24, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 22, 2015

Trademark Statements

Disclaimer with Predetermined Text"MITOCHONDRIAL MEDICINE"
Goods and ServicesBiopharmaceutical preparations which target cell mitochondria and are used for the prevention and treatment of cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; biological preparations which target cell mitochondria and are used for the prevention of and treatment of cellular abnormalities
Goods and ServicesScientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the cardiovascular, renal, ophthalmic, neurologic and metabolic system fields

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 19, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 19, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTEALTH BIOTHERAPEUTICS CORP
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address3-5 AVENUE DES CITRONNIERS MC98000
MC
Party NameSTEALTH BIOTHERAPEUTICS CORP
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
Address3-5 AVENUE DES CITRONNIERS MC98000
MC
Party NameStealth Peptides International Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMC98000
MC

Trademark Events

Event DateEvent Description
Monday, December 24, 2018ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 24, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 7, 2018EXTENSION 5 GRANTED
Tuesday, April 24, 2018EXTENSION 5 FILED
Monday, May 7, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 24, 2018TEAS EXTENSION RECEIVED
Wednesday, November 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2017EXTENSION 4 GRANTED
Monday, November 13, 2017EXTENSION 4 FILED
Monday, November 13, 2017TEAS EXTENSION RECEIVED
Saturday, May 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 11, 2017EXTENSION 3 GRANTED
Thursday, May 11, 2017EXTENSION 3 FILED
Thursday, May 11, 2017TEAS EXTENSION RECEIVED
Friday, November 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 17, 2016EXTENSION 2 GRANTED
Wednesday, November 2, 2016EXTENSION 2 FILED
Wednesday, November 16, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 2, 2016TEAS EXTENSION RECEIVED
Saturday, April 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 21, 2016EXTENSION 1 GRANTED
Thursday, April 21, 2016EXTENSION 1 FILED
Thursday, April 21, 2016TEAS EXTENSION RECEIVED
Tuesday, November 17, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 22, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 22, 2015PUBLISHED FOR OPPOSITION
Wednesday, September 2, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 26, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, August 20, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 18, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 18, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, August 18, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 18, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, August 18, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 11, 2015PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, July 21, 2015WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, July 4, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 1, 2015ASSIGNED TO LIE
Tuesday, June 16, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 16, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, June 16, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 16, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, June 16, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, March 9, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 9, 2015NON-FINAL ACTION E-MAILED
Monday, March 9, 2015NON-FINAL ACTION WRITTEN
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Wednesday, November 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 15, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

medicine mitochondrial leading research ophthalmic renal biopharmaceutical scientific development cardiovascular metabolic neurologic which